288 results on '"Tricklebank, Mark"'
Search Results
2. Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology
3. Amphetamine disrupts haemodynamic correlates of prediction errors in nucleus accumbens and orbitofrontal cortex
4. Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)
5. Serotonin and aggression
6. The metabolism of indoleamines
7. Endocrine and genetic moderation of serotonin systems and the psychopathology of affective disorders
8. Dedication
9. List of Contributors
10. Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder
11. Serotonin and the psychedelics
12. The outlook for the development of serotonergic drugs as therapeutic medications for psychiatric disorders
13. Serotonin and sleep
14. Preface
15. Distinct hippocampal-prefrontal neural assemblies coordinate memory encoding, maintenance, and recall
16. Correction to: Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology
17. Review of: "Dopamine D5 receptor involvement in LTP and LTD: adjustment to the dysconnectivity theory of schizophrenia"
18. The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments)
19. Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat
20. Distinct pro-vigilant profile induced in rats by the mGluR5 potentiator LSN2814617
21. Dissociation of mGlu2/3 agonist effects on ketamine-induced regional and event-related oxygen signals
22. Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia
23. Changes in reward-related signals in the rat nucleus accumbens measured by in vivo oxygen amperometry are consistent with fMRI BOLD responses in man
24. “Prefrontal cortical contributions to working memory loading, maintenance and recall are parsed by hippocampal-prefrontal oscillatory assembly dynamics”
25. Preclinical screening for antidepressant activity – shifting focus away from the Forced Swim Test to the use of translational biomarkers
26. Development of an implantable d-serine biosensor for in vivo monitoring using mammalian d-amino acid oxidase on a poly ( o-phenylenediamine) and Nafion-modified platinum–iridium disk electrode
27. Real-time electrochemical monitoring of brain tissue oxygen: A surrogate for functional magnetic resonance imaging in rodents
28. Editorial: Dopaminergic Alterations in Schizophrenia
29. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory
30. A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists
31. An automated maze task for assessing hippocampus-sensitive memory in mice
32. Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia
33. Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
34. Ligands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat
35. Mapping the central effects of ketamine in the rat using pharmacological MRI
36. Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging
37. The Possibilities and Limitations of Animal Models for Psychiatric Disorders
38. Hemodynamic responses in amygdala and hippocampus distinguish between aversive and neutral cues during Pavlovian fear conditioning in behaving rats
39. In vitro characterisation of the novel positive allosteric modulators of the mGlu5 receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat
40. The mGlu5 positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat
41. NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis☆
42. Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia
43. Close temporal coupling of neuronal activity and tissue oxygen responses in rodent whisker barrel cortex
44. Amphetamine disrupts haemodynamic correlates of prediction errors in nucleus accumbens and orbitofrontal cortex
45. Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs
46. Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat
47. Use of the elevated plus maze in the search for novel anxiolytic agents
48. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure
49. TaiNi: maximizing research output whilst improving animals' welfare in neurophysiology experiments
50. The IMPROVE Guidelines (ischaemia models: procedural refinements of in vivo experiments)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.